花园生物(300401.SZ)：2025年中报净利润为1.62亿元

Core Insights - Garden Biotech (300401.SZ) reported its 2025 mid-year financial results, highlighting significant revenue and profit figures [1] Financial Performance - The company's total revenue reached 635 million yuan, with a net profit attributable to shareholders of 162 million yuan. The net cash inflow from operating activities was 275 million yuan [2] - The latest asset-liability ratio stands at 40.98%, an increase of 1.35 percentage points from the previous quarter. The gross profit margin is 55.94%, down by 0.86 percentage points from the previous quarter and down by 1.39 percentage points year-on-year. The latest return on equity (ROE) is 4.83% [4] Earnings and Ratios - The diluted earnings per share (EPS) is 0.30 yuan. The total asset turnover ratio is 0.11 times, and the inventory turnover ratio is 0.35 times [5] - The number of shareholders is 33,400, with the top ten shareholders holding a total of 192 million shares, accounting for 35.33% of the total share capital [5] Shareholding Structure - The largest shareholder is Zhejiang Xiangyun Technology Co., Ltd., holding 26.57% of the shares. Other notable shareholders include Shao Junfang (3.06%) and the employee stock ownership plan of Zhejiang Garden Biotech (1.05%) [5]